SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-22-037384
Filing Date
2022-02-11
Accepted
2022-02-11 17:12:53
Documents
1
Group Members
AMY SCHULMANPOLARIS ENTREPRENEURS' FUND VII, L.P.POLARIS PARTNERS VII, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d251569dsc13da.htm SC 13D/A 82442
  Complete submission text file 0001193125-22-037384.txt   84077
Mailing Address 200 ARSENAL YARDS BLVD., STE. 210 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., STE. 210 WATERTOWN MA 02472 617-898-8824
SQZ Biotechnologies Co (Subject) CIK: 0001604477 (see all company filings)

IRS No.: 462431115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91838 | Film No.: 22622648
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE MARINA PARK DRIVE, 10TH FLOOR BOSTON MA 02210
Business Address ONE MARINA PARK DRIVE, 10TH FLOOR BOSTON MA 02210 855-787-3500
Polaris Management Co. VII, L.L.C. (Filed by) CIK: 0001678203 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A